BG
PTX

BlackRock Group’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

BlackRock Group’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,224
Closed -$44K – 3071
2016
Q1 		$44K Hold
4,224
– – ﹤0.01% 2949
2015
Q4 		$125K Hold
4,224
– – ﹤0.01% 2620
2015
Q3 		$133K Buy
+4,224
New +$202K ﹤0.01% 2631

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

BlackRock Group's PTX Position: Q2 2016 in Review

BlackRock Group sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2016, closing a stake of 4,224 shares — an estimated $44K sold.

BlackRock Group first reported a position in PTX in Q3 2015 and held it in 3 quarters. The position peaked at $133K in Q3 2015. 56 funds tracked by Wall St. Rank hold PTX as of Q2 2016.

  • BlackRock Group reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
  • BlackRock Group sold 4,224 Pernix Therapeutics Holdings, Inc. shares in Q2 2016, an estimated $44K.
  • BlackRock Group first reported a position in Pernix Therapeutics Holdings, Inc. in Q3 2015 and held it in 3 quarters.
  • BlackRock Group's Pernix Therapeutics Holdings, Inc. position peaked at $133K in Q3 2015.
  • 56 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2016.

Based on BlackRock Group's 13F filing for Q2 2016, filed 10 Aug 2016.